At EBERS Solutions, we work with pharma teams to build reporting models that are lean, flexible, and designed for real use — not just delivery. Every collaboration helps us refine the system. That’s how we reduce cost, effort, and turnaround time – without cutting corners.
Our model isn’t just about delivering outputs — it’s about embedding flexibility, efficiency, and collaboration into the processes pharma teams rely on every day.
Exposure-adjusted incidence tables, cumulative listings, and safety summaries — tailored for DSUR requirements with fast adaptability to MedDRA versions and data cuts.
AE/SAE summaries and exposure tables — streamlined for Investigator’s Brochures with flexible integration across protocols and consistent formatting.
Optimized delivery of blinded and unblinded TLFs — enabling fast reruns, protocol flexibility, and timely DSMB or internal data reviews with minimal manual effort.
Template-based narrative generation using safety datasets and MedDRA coding — optimized to reduce writing workload and support high-volume safety reporting with consistency.
Targeted outputs like patient profiles, safety listings, and subgroup summaries — built for rapid turnaround, audit readiness, and high-stakes regulatory interactions.
Cumulative safety summaries and benefit–risk views across studies — supporting internal reviews and signal detection before formal submissions. Tailored for flexibility and rapid iteration in multi-study portfolios.Tailored cumulative AE/SAE summaries, exposure tables, and safety snapshots — built to support internal safety reviews, benefit-risk assessments, and cross-study insights before formal submission phases.
Custom listings and visual summaries built around sponsor-specific questions — designed to support internal reviews, trend exploration, and real-time insights during ongoing trial phases.
Subject-level listings that present detailed safety and efficacy data per patient — designed for medical review, signal detection, and submission support. Easily customized by domain, filter, or protocol-specific needs.
Focused summaries of protocol violations by patient and category — structured to support deviation trend analysis, CSR inclusion, and audit readiness.
Tailored output generation for both blinded and unblinded states — enabling compliant, efficient analysis for DSMBs, interim reviews, or final database lock with clear version control.
Independent verification of third-party deliverables — including safety tables, listings, and reports — to ensure accuracy, consistency, and alignment with sponsor expectations before regulatory submission or internal use.
In today’s fast-paced pharmaceutical industry and clinical trials landscape, efficiency, accuracy, and real-time insights are critical. Our expertise in Data Management, Statistical Programming, and Biostatistics allows us to develop tailored automation solutions that streamline workflows, enhance data integrity, and accelerate decision-making.
Transforming Processes with Automation
We specialize in designing and implementing intelligent automation that optimizes complex processes, ensuring consistency, precision, and efficiency across clinical studies. Our solutions are built to adapt to specific client needs, integrating seamlessly into existing workflows to maximize productivity.
Automated Listing Generation Across Studies
One of our key automation solutions enables seamless medical listing generation throughout a clinical trial. This process offers:
Our automation solutions minimize manual effort, reduce errors, and enhance data-driven decision-making, allowing teams to focus on critical insights rather than repetitive tasks.
